$0.00010
At close: Feb 9, 1:53 PM EDT
Comments
Loading...
Mid-Atlantic Home Health Analyst Ratings and Price Targets | OTC:MAHN | Benzinga
Mid-Atlantic Home Health Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Mid-Atlantic Home Health Corp from these most-recent analyst ratings.
Analyst Ratings for Mid-Atlantic Home Health
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Mid-Atlantic Home Health (MAHN) stock?
There is no price target for Mid-Atlantic Home Health
What is the most recent analyst rating for Mid-Atlantic Home Health (MAHN)?
There is no analyst for Mid-Atlantic Home Health
When was the last upgrade for Mid-Atlantic Home Health (MAHN)?
There is no last upgrade for Mid-Atlantic Home Health
When was the last downgrade for Mid-Atlantic Home Health (MAHN)?
There is no last downgrade for Mid-Atlantic Home Health.
When is the next analyst rating going to be posted or updated for Mid-Atlantic Home Health (MAHN)?
There is no next analyst rating for Mid-Atlantic Home Health.
Is the Analyst Rating Mid-Atlantic Home Health (MAHN) correct?
There is no next analyst rating for Mid-Atlantic Home Health.
Browse analyst ratings and price targets on all stocks.
